Work

Deriving Risk-Adapted Screening Initial Age of Colorectal Cancer According to Steatotic Liver Disease Subtypes

Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Background: Evidence on steatotic liver disease (SLD)-specific colorectal cancer (CRC) risk and implications for screening is limited. We aimed to estimate how many years earlier individuals with SLD, including metabolic dysfunction-associated SLD (MASLD), metabolic and alcohol-related liver disease (MetALD), and alcohol-related liver disease (ALD), reach equivalent CRC risk versus those without. Methods: The primary outcome was incident CRC. We used Cox regression models to estimate adjusted hazard ratios (aHRs), population attributable fractions (PAFs), and risk advancement periods (RAPs). A newly developed framework with age-specific national CRC incidence rates was also applied to estimate risk-adapted CRC screening starting ages in large European countries. Results: 191,837participants were included. Compared with no SLD, aHRs (95% CIs) for CRC were 1.17 (1.05–1.32) for MASLD, 1.41 (1.21–1.63) for MetALD, and 1.58 (1.27–1.95) for ALD; PAFs were 4.2%, 3.3%, and 1.6%, respectively; the PAF for MASLD and MetALD was higher than that of family history of CRC (2.4%). These associations were independent of family history of CRC and cardiometabolic risk factors. Consistent with RAPs, these subtypes reached average-risk CRC incidence 2–6 years earlier than individuals without. Results were similar across countries despite variation in absolute incidence. Conclusions: Individuals with SLD show a graded increase in CRC risk corresponding to 2-6 years earlier risk attainment, supporting their consideration in risk-adapted CRC screening strategies.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: green
OpenAlex ID: W7236794368
Cites: 28
Cited by:
Related to: 10